A Diversified Portfolio of Generic and Specialty Pharmaceutical Products
Providing patients with high-quality medicines is the heart of what we do. We maintain a broad and growing portfolio of medicines that meet patient needs across a wide range of therapeutic categories.
Our Impax Generics portfolio currently has more than 60 marketed products that are the pharmaceutical and therapeutic equivalents of various brand-name drug products. These high-quality products provide affordable alternatives for many patients.
Our Specialty Pharma portfolio of marketed products are helping to meet unmet medical needs in central nervous system disorders, infectious disease and other therapeutic areas.